This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Leland Stanford Junior University. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Innovations of Murray H Kown in Cardiovascular Research
Introduction
Murray H Kown is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of cardiovascular research, particularly through his innovative patent that addresses cell proliferation in blood vessels.
Latest Patents
Murray H Kown holds a patent titled "Method and composition for inhibiting cardiovascular cell proliferation." This invention focuses on inhibiting cardiovascular cell proliferation in blood vessels subjected to trauma, such as angioplasty, vascular graft, anastomosis, or organ transplant. The method involves contacting the vessel with a polymer consisting of 6 to about 30 amino acid subunits, where at least 50% of the subunits are arginine. Notably, the polymer must contain at least six contiguous arginine subunits. Exemplary polymers for this purpose include arginine homopolymers that are 7 to 15 subunits in length. This innovative approach has the potential to improve outcomes in various cardiovascular procedures.
Career Highlights
Murray H Kown is affiliated with Leland Stanford Junior University, where he continues to advance research in cardiovascular health. His work has garnered attention for its practical applications in medical treatments and interventions.
Collaborations
Murray has collaborated with esteemed colleagues such as John P Cooke and Garrison C Fathman. These partnerships have further enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Murray H Kown's contributions to cardiovascular research through his patent demonstrate his commitment to improving medical practices. His innovative methods hold promise for enhancing patient care in cardiovascular procedures.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
